Bristol-Myers Squib Pharmaceuticals Ltd has decided to discontinue Buspar 5mg and 10mg from the end of December 2009. The decision has been taken for operational reasons and affects all European markets. Alternative treatments are available. Should you have any queries, please contact their Medical Information Department on (01) 2913800.
Reckitt Benckiser Ireland Ltd wish to advise you that Nurofen Meltlets is no longer available in Ireland. The product has been discontinued from the Irish market for rationalisation reasons. For any further queries, please contact Reckitt Benckiser on (01) 6305429.
Novartis Ireland Ltd announce the discontinuation of Viskaldix tablets, pack size 28s and Visken 5mg tablets, pack sizes 50s, 56s & 100s from 29th September 2009. For further information please contact Novartis on (01) 2601255.
Nexium IV (esomeprazole) has been approved in Ireland for prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. Currently, it is the only proton pump inhibitor (PPI) to be licensed in Ireland for this condition. Nexium Tablets has also been granted a licence for prolonged treatment after IV induced prevention of [...]
IMB Guidance on possible interaction between Clopidogrel and Proton Pump Inhibitors Clopidogrel is an antiplatelet drug authorised for the prevention of atherothrombotic events in patients suffering from myocardial infarction, ischaemic stroke or acute coronary syndrome, or those at risk of these problems. Published reports have suggested that clopidogrel (marketed as Plavix) is less effective in [...]
Loading ...
